These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 15886704)
21. Photochemical internalization (PCI) in cancer therapy: from bench towards bedside medicine. Norum OJ; Selbo PK; Weyergang A; Giercksky KE; Berg K J Photochem Photobiol B; 2009 Aug; 96(2):83-92. PubMed ID: 19467605 [TBL] [Abstract][Full Text] [Related]
22. Photodynamic modification of disulfonated aluminium phthalocyanine fluorescence in a macrophage cell line. Kunz L; Connelly JP; Woodhams JH; MacRobert AJ Photochem Photobiol Sci; 2007 Sep; 6(9):940-8. PubMed ID: 17721592 [TBL] [Abstract][Full Text] [Related]
23. Light dosimetry for intraperitoneal photodynamic therapy in a murine xenograft model of human epithelial ovarian carcinoma. Lilge L; Molpus K; Hasan T; Wilson BC Photochem Photobiol; 1998 Sep; 68(3):281-8. PubMed ID: 9747583 [TBL] [Abstract][Full Text] [Related]
24. Initiation of apoptosis by photodynamic therapy using a novel positively charged and water-soluble near infra-red photosensitizer and white light irradiation. Schastak S; Yafai Y; Geyer W; Kostenich G; Orenstein A; Wiedemann P Methods Find Exp Clin Pharmacol; 2008; 30(1):17-23. PubMed ID: 18389094 [TBL] [Abstract][Full Text] [Related]
26. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo. Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168 [TBL] [Abstract][Full Text] [Related]
27. Cellular inactivation and antitumor efficacy of a new zinc phthalocyanine with potential use in photodynamic therapy. Vittar NB; Prucca CG; Strassert C; Awruch J; Rivarola VA Int J Biochem Cell Biol; 2008; 40(10):2192-205. PubMed ID: 18440266 [TBL] [Abstract][Full Text] [Related]
28. Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models. Zhou Q; Olivo M; Lye KY; Moore S; Sharma A; Chowbay B Cancer Chemother Pharmacol; 2005 Dec; 56(6):569-77. PubMed ID: 16001166 [TBL] [Abstract][Full Text] [Related]
29. Antitumor effect of photodynamic therapy in mice using direct application of Photofrin dissolved in lidocaine jelly. Murakami H; Kohno E; Kohmura Y; Ozawa H; Ito H; Sugihara K; Horiuchi K; Hirano T; Kanayama N Photodermatol Photoimmunol Photomed; 2009 Oct; 25(5):259-63. PubMed ID: 19747245 [TBL] [Abstract][Full Text] [Related]
30. Intraoperative photodynamic therapy of the chest cavity in malignant pleural mesothelioma bearing rats. Krueger T; Pan Y; Tran N; Altermatt HJ; Opitz I; Ris HB Lasers Surg Med; 2005 Oct; 37(4):271-7. PubMed ID: 16245295 [TBL] [Abstract][Full Text] [Related]
31. Long-term regression of the murine mammary adenocarcinoma, LM3, by repeated photodynamic treatments using meso-tetra (4-N-methylpyridinium) porphine. Colombo LL; Vanzulli SI; Villanueva A; CaƱete M; Juarranz A; Stockert JC Int J Oncol; 2005 Oct; 27(4):1053-9. PubMed ID: 16142323 [TBL] [Abstract][Full Text] [Related]
32. Photodynamic therapy with phthalocyanine sensitisation: quantitative studies in a transplantable rat fibrosarcoma. Tralau CJ; MacRobert AJ; Coleridge-Smith PD; Barr H; Bown SG Br J Cancer; 1987 Apr; 55(4):389-95. PubMed ID: 3580264 [TBL] [Abstract][Full Text] [Related]
33. Evidence for a bystander role of neutrophils in the response to systemic 5-aminolevulinic acid-based photodynamic therapy. de Bruijn HS; Sluiter W; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ Photodermatol Photoimmunol Photomed; 2006 Oct; 22(5):238-46. PubMed ID: 16948825 [TBL] [Abstract][Full Text] [Related]
34. Fluorescence image-guided brain tumour resection with adjuvant metronomic photodynamic therapy: pre-clinical model and technology development. Bogaards A; Varma A; Zhang K; Zach D; Bisland SK; Moriyama EH; Lilge L; Muller PJ; Wilson BC Photochem Photobiol Sci; 2005 May; 4(5):438-42. PubMed ID: 15875077 [TBL] [Abstract][Full Text] [Related]
35. A non-laser light source for photodynamic therapy: in vitro effects on normal and malignant cells. Kashtan H; Haddad R; Greenberg R; Skornick Y; Kaplan O J Med; 2002; 33(1-4):93-104. PubMed ID: 12939108 [TBL] [Abstract][Full Text] [Related]
36. Fractionated photodynamic therapy for a human oral squamous cell carcinoma xenograft. Togashi H; Uehara M; Ikeda H; Inokuchi T Oral Oncol; 2006 May; 42(5):526-32. PubMed ID: 16466960 [TBL] [Abstract][Full Text] [Related]
37. Biodistribution and photodynamic therapy with hypericin in a human NPC murine tumor model. Du HY; Bay BH; Olivo M Int J Oncol; 2003 May; 22(5):1019-24. PubMed ID: 12684667 [TBL] [Abstract][Full Text] [Related]
38. Comparison of photodynamic therapy with phthalocyanine and photofrin in human colorectal carcinoma. Stukavec J; Horak L; Duchac V; Jirasek T; Rakusan J; Karaskova M; Pouckova P Neoplasma; 2008; 55(2):127-9. PubMed ID: 18237250 [TBL] [Abstract][Full Text] [Related]
39. [Photosensitizer nanoparticles photodynamic therapy on LOVO human colon cancer xenografts in athymic mice]. Qing SH; Li LY; Sheng XH; Ba MC Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):530-3. PubMed ID: 17143803 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of Hypocrellin B in a human bladder tumor model in experimental photodynamic therapy: biodistribution, light dose and drug-light interval effects. Chin W; Lau W; Cheng C; Olivo M Int J Oncol; 2004 Sep; 25(3):623-9. PubMed ID: 15289863 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]